Literature DB >> 11306498

Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis.

M Jeffers1, R Shimkets, S Prayaga, F Boldog, M Yang, C Burgess, E Fernandes, B Rittman, J Shimkets, W J LaRochelle, H S Lichenstein.   

Abstract

The fibroblast growth factor (FGF) family of signaling molecules has been implicated in normal developmental and physiological processes, as well as in human malignancy. Using a homology-based genomic DNA mining process, we identified a human gene encoding a novel member of the FGF family, that we designate FGF-20. The FGF-20 cDNA was isolated, and its sequence confirmed the gene prediction. FGF-20 is expressed in normal brain, particularly the cerebellum, and in some cancer cell lines. Recombinant FGF-20 protein induces DNA synthesis in a variety of cell types and is recognized by multiple FGF receptors. Ectopic expression of FGF-20 in NIH 3T3 cells renders the cells transformed in vitro and tumorigenic in nude mice. These results underscore the utility of mining genomic DNA databases and reveal FGF-20 to be a novel oncogene that may play a role in human cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306498

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Genetic variation in FGF20 modulates hippocampal biology.

Authors:  Herve Lemaitre; Venkata S Mattay; Fabio Sambataro; Beth Verchinski; Richard E Straub; Joseph H Callicott; Raja Kittappa; Thomas M Hyde; Barbara K Lipska; Joel E Kleinman; Ronald McKay; Daniel R Weinberger
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

Review 2.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

3.  FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development.

Authors:  Mario N Chamorro; Donald R Schwartz; Alin Vonica; Ali H Brivanlou; Kathleen R Cho; Harold E Varmus
Journal:  EMBO J       Date:  2004-12-09       Impact factor: 11.598

4.  Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.

Authors:  M Kornmann; M E Lopez; H G Beger; M Korc
Journal:  Int J Pancreatol       Date:  2001

5.  Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant.

Authors:  Michael W Schuster; Tsiporah B Shore; John G Harpel; June Greenberg; Bita Jalilizeinali; Scott Possley; Robert W Gerwien; William Hahne; Yuan-Di C Halvorsen
Journal:  Support Care Cancer       Date:  2007-08-21       Impact factor: 3.603

6.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 7.  Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.

Authors:  Jin-Hong Chang; Yu-Hui Huang; Christy M Cunningham; Kyu-Yeon Han; Michael Chang; Motoharu Seiki; Zhongjun Zhou; Dimitri T Azar
Journal:  Surv Ophthalmol       Date:  2015-12-02       Impact factor: 6.048

8.  Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.

Authors:  Joelle M van der Walt; Maher A Noureddine; Raja Kittappa; Michael A Hauser; William K Scott; Ron McKay; Fengyu Zhang; Jeffrey M Stajich; Kenichiro Fujiwara; Burton L Scott; Margaret A Pericak-Vance; Jeffery M Vance; Eden R Martin
Journal:  Am J Hum Genet       Date:  2004-04-30       Impact factor: 11.025

9.  Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.

Authors:  Ruixia Zhu; Ying Zhu; Xu Liu; Zhiyi He
Journal:  Neurol Sci       Date:  2014-06-19       Impact factor: 3.307

10.  The zebrafish secretome.

Authors:  Eric W Klee
Journal:  Zebrafish       Date:  2008       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.